Insmed Incorporated
INSM
$67.22
$1.612.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 92.82M | 104.44M | 93.43M | 90.34M | 75.50M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 92.82M | 104.44M | 93.43M | 90.34M | 75.50M |
| Cost of Revenue | 21.28M | 26.15M | 21.17M | 20.96M | 17.46M |
| Gross Profit | 71.55M | 78.29M | 72.26M | 69.38M | 58.04M |
| SG&A Expenses | 147.55M | 142.52M | 118.93M | 106.57M | 93.10M |
| Depreciation & Amortization | 1.26M | 1.26M | 1.26M | 1.26M | 1.26M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 322.66M | 349.66M | 292.17M | 275.54M | 232.91M |
| Operating Income | -229.84M | -245.21M | -198.75M | -185.20M | -157.41M |
| Income Before Tax | -255.67M | -234.28M | -219.51M | -299.77M | -156.50M |
| Income Tax Expenses | 912.00K | 1.27M | 1.01M | 838.00K | 589.00K |
| Earnings from Continuing Operations | -256.58M | -235.55M | -220.52M | -300.61M | -157.09M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -256.58M | -235.55M | -220.52M | -300.61M | -157.09M |
| EBIT | -229.84M | -245.21M | -198.75M | -185.20M | -157.41M |
| EBITDA | -227.23M | -243.01M | -196.56M | -183.04M | -155.09M |
| EPS Basic | -1.42 | -1.32 | -1.27 | -1.94 | -1.06 |
| Normalized Basic EPS | -0.82 | -0.87 | -0.74 | -0.79 | -0.71 |
| EPS Diluted | -1.42 | -1.32 | -1.27 | -1.94 | -1.06 |
| Normalized Diluted EPS | -0.82 | -0.87 | -0.74 | -0.79 | -0.71 |
| Average Basic Shares Outstanding | 180.86M | 179.02M | 173.72M | 154.70M | 148.46M |
| Average Diluted Shares Outstanding | 180.86M | 179.02M | 173.72M | 154.70M | 148.46M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |